Feature

Biotechnology drugs: Integrated single-use technologies for biopharmaceuticals

26 January 2010
Christine Valle

A transition to integrated single-use technologies is helping to adapt to the challenges of bringing biotechnology drugs to market. Christine Valle explains the approach being taken at Millipore.

Register

Creating an account only takes a few moments and will give you instant access to hundreds of specially selected features across the magazine.

This article is featured in:
Filter media • Pharma and biotech

Comment on this article

You must be registered and logged in to leave a comment about this article.